Lee DG, Hahm KS, Park Y, Kim HY, Lee W, Lim SC, et al
Updated testing disclosures can support this process by providing additional insight into product verification practices and quality control measures
Delivers to EU in 3-7 business days Free shipping over 200 no customs paperwork (EU) via EU carrier network Free shipping on orders over 200 BPC-157 (Body Protection Compound 157) is a stable 15-amino-acid pentadecapeptide fragment derived from a gastric juice protein, supplied by CertaPeptides as a lyophilized laboratory research compound (≥98% supplier batch specification
In physical dependence assay (isoniazid challenge assessed at 6, 14, 42 and 72 h after conditioning medication), when compared to diazepam non-conditioned healthy mice, in diazepam conditioned mice residual anticonvulsive activity was not present already at the earliest post-conditioning interval (i.e., not different latency to isoniazid-convulsions), whereas shorter preconvulsive latencies (as physical dependence/withdrawal hallmark) were noted in diazepam conditioned mice following isoniazid challenge at 42 h and at 72 h after end of conditioning treatment
